AliveCor QT Service

by AliveCor  · Based in United States → — Saving lives and transforming cardiology by delivering intelligent, highly-personalized heart data to clinicians and patients anytime, anywhere.
Cardiology Emergency Medicine Internal Medicine

Varies by product and service, with subscription options available.
Regulatory Status Disclosed

Overview

The AliveCor QT Service (often utilized via the InstantQT software and K1000 or KardiaMobile 6L devices) is a point-of-care cardiac safety solution designed to measure and monitor QT and corrected QT (QTc) intervals in seconds. By utilizing AI-enabled, machine learning-powered ECG sensors, the service allows healthcare professionals to evaluate patients for potentially dangerous changes in cardiac activity without requiring a traditional, complex 12-lead ECG setup.

This service is primarily designed for:

  • Psychiatrists and Mental Health Professionals: To screen and monitor patients prescribed psychotropic medications known to cause QT prolongation.
  • Oncologists and Infectious Disease Specialists: To manage cardiac safety for patients on therapies with known cardiotoxic or QT-prolonging side effects.
  • Clinical Trial Sponsors and Biopharma Partners: To integrate decentralized cardiac safety monitoring and real-world evidence collection into drug development pipelines.

In a clinical workflow, the service eliminates the need for external cardiology referrals for routine QT screening. Clinicians or patients can capture a medical-grade, 6-lead ECG in 30 seconds. The integrated software instantly processes the rhythm, calculates the QTc interval, and flags potential prolongations. This rapid assessment supports immediate clinical decision-making, accelerates therapy starts, and enhances patient safety during ongoing medication titration.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Cloud-based Software as a Medical Device (SaMD)
  • Measures QT and QTc intervals (Bazett's and Fridericia's formulas)
  • Analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L)
  • Prescription (Rx) use only, for qualified healthcare professionals
  • Utilizes AI and deep neural networks for ECG analysis
  • Provides instant QT measurements (as InstantQT)
  • Integrates with KardiaStation app and KardiaPro portal
  • API available for integration with EHR, SDK, CRM, EDC, and PSP platforms
  • Secure, unlimited cloud storage for ECG data
  • Supports remote ECG recording and monitoring

Use Cases

  • Screening for QT prolongation before prescribing or titrating QT-prolonging medications (e.g., antipsychotics, certain antibiotics, cancer therapies)
  • Monitoring cardiac safety in clinical trials and drug development
  • Identifying patients at risk for Torsades de Pointes (TdP) and sudden cardiac death
  • Supporting rapid clinical decision-making at the point of care
  • Remote patient monitoring of cardiac health
  • Integration into existing practice workflows and EHR systems

What Physicians Need to Know

ECG/EKG Analysis Capability
The AliveCor QT Service analyzes 30 seconds of previously acquired electrocardiograms (ECGs) from AliveCor's 6-Lead ambulatory ECG devices, specifically those analyzed as normal sinus rhythm by KardiaAI, to compute QT and QTc interval measurements. It utilizes internal algorithms, including deep neural networks (DNN), trained and validated on over 750,000 ECGs from more than 250,000 patients. The service provides QT and QTc interval measurements with a mean interval difference of ≤ ± 20ms and a standard deviation of interval difference of ≤ 25ms when compared to expert-annotated reference intervals from a supine, diagnostic bandwidth, 12-lead ECG. The KardiaMobile 6L, used with the service, records Lead II data, which offers a more accurate view of the QTc interval compared to Lead I. AliveCor's AI algorithms can automatically classify ECGs into categories such as normal sinus rhythm, possible AFib, tachycardia, or bradycardia. The K1000, powered by AI, instantly detects seven common heart rhythms and provides InstantQT™ for QT and QTc interval measurements. Additionally, clinicians can assess over 20 additional heart rhythms for a complete cardiac safety profile.
Arrhythmia Detection Accuracy
The AliveCor QT Service provides QT and QTc interval measurements only on ECGs analyzed as Normal Sinus Rhythm by KardiaAI. The KardiaMobile 6L device, used with the service, is FDA-cleared for the detection of atrial fibrillation, bradycardia, and tachycardia. Studies have shown high accuracy levels for the KardiaMobile arrhythmia-detecting algorithm, with one study demonstrating a sensitivity rate of 96.6% and specificity of 94% in detecting atrial fibrillation. A new study showed that 30-day use of the KardiaMobile 6L nearly doubled the number of clinically significant arrhythmias found compared to traditional short-duration ambulatory ECG monitoring alone. The deep neural network used in a study to identify patients with congenital Long QT Syndrome (LQTS) achieved an area under the curve of 0.83, with 81% specificity, 73% sensitivity, and an overall accuracy of 79%. The K1000, powered by AI, instantly detects seven common heart rhythms and can assess over 20 additional heart rhythms with clinician analysis.
Cardiac Monitoring Integration
The AliveCor QT Service is a cloud-based Software as a Medical Device (SaMD) that integrates with AliveCor-designed 6-Lead ambulatory ECG devices. Healthcare professionals can access the service over the internet from patient management and ECG storage Medical Device Data Systems (MDDS) or other prescription-use-only medical data software devices. The service uses a REST-based application program interface (API) for analysis requests. AliveCor offers EHR Integration, SDK, and API solutions to allow partners to build apps with ECG monitoring capabilities or integrate patient ECG data into their systems. ECGs can be automatically pulled into EHR systems, and AliveCor partners with leading EHR software and cardiac information management systems like GE Healthcare's MUSE™ NX. KardiaPro is a web-based portal for remote monitoring of patient ECG, blood pressure, and weight data, allowing for management and review of data between appointments. KardiaStation, when paired with KardiaPro, functions as a streamlined point-of-care solution.
AHA/ACC Guideline Alignment
Information specifically detailing AHA/ACC guideline alignment for AliveCor QT Service is not explicitly provided. However, the service focuses on QT interval assessment, which is a critical aspect of cardiac safety monitoring recommended by regulatory agencies like the FDA and EMA for new drugs.
Real-Time Alert Capability
The AliveCor QT Service provides instant access to feedback, supporting timely clinical decision-making. Webhook notifications can alert systems when a new ECG is available. The K1000, powered by AI, instantly detects seven common heart rhythms and provides InstantQT™, which displays QT and QTc interval measurements in seconds. The service aims to provide immediate access to data for physicians.
Physician Tip

The AliveCor QT Service is a prescription-use-only device intended for qualified healthcare professionals, including trained ECG technicians. It is indicated for adult patients (over 18 years) and is not intended for pediatric use or for use in life-supporting systems, continuous ECG monitors, or cardiac alarm devices. The service is particularly useful for monitoring QT intervals in patients taking medications known to cause QT prolongation, such as antipsychotics and some cancer treatments, to prevent potentially dangerous arrhythmias like Torsades de Pointes. The KardiaMobile 6L device, used with the service, can capture medical-grade ECGs without wires, patches, or gels, making it suitable for point-of-care and remote monitoring. The system can streamline QT screening, which can otherwise cause treatment delays. The ability to obtain QTc measurements rapidly can help guide the safe use of drugs and reduce the burden on healthcare systems. The service can also be integrated into existing practice workflows through the KardiaPro web-based portal or EHR integration options.

AliveCor offers EHR Integration, SDK, and API solutions to allow third-party providers to manage patient heart conditions and integrate patient ECG data into their own systems. ECGs can be automatically and seamlessly pulled into EHR systems, with partnerships existing with leading EHR software and cardiac information management systems like GE Healthcare's MUSE™ NX. The AliveCor API allows access to patient data stored in the cloud through KardiaPro, enabling easy import into other systems. The SDK allows developers to use AliveCor's ECG recording and Kardia AI technology within their own apps, connecting with the KardiaMobile 6L device, initiating ECG recordings, displaying waveforms, and interpreting results. The AliveCor QT Service itself uses a REST-based API for analysis requests. KardiaPro, a web-based portal, integrates with KardiaStation for streamlined point-of-care and remote patient management.

Details

Category Cardiology AI, Pharmacology & Dosing AI
Pricing Varies by product and service, with subscription options available.
DeploymentMobile app, cloud-based platform, EHR integration.
Mobile AppYes, AliveCor offers mobile applications for both healthcare providers and patients.
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
SOC 2 Yes AI-estimated
GDPR Yes AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Emergency Medicine, Internal Medicine

Support & Reliability

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2022-04-26K212662 510(k)AliveCor QT Service

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate AliveCor QT Service

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for AliveCor QT Service.

View all on YouTube

Frequently Asked Questions

The AliveCor QT Service uses deep neural networks and other algorithms to analyze 30-second ECGs from AliveCor's 6-lead ambulatory ECG devices to compute QT and heart-rate corrected QTc intervals. This AI-powered analysis helps in the rapid detection of potentially dangerous QT prolongation, which can be a side effect of various medications.
The AliveCor QT Service is FDA-cleared for use by healthcare professionals to measure QTc intervals. It is intended for prescription use only in professional medical facilities and is indicated for adult patients over 18 years old. AliveCor also adheres to stringent data security and compliance practices, including HIPAA compliance and SOC2 Type 1 and Type 2 attestations.
The AliveCor QT Service provides QT and QTc interval measurements only on ECGs analyzed as Normal Sinus Rhythm by KardiaAI. It is intended for adult patients (over 18 years) and has not been tested or intended for pediatric use. Additionally, the service is not intended for use in life-supporting or sustaining systems.
While traditional 12-lead ECGs are a well-established method for QT interval monitoring, they typically require in-clinic visits and specialized infrastructure. The Apple Watch also has an ECG feature, though its single-lead technology is comparatively limited in detecting various heart conditions.
The AliveCor QT Service, often used with the KardiaMobile 6L device and KardiaStation app, allows for quick ECG capture in the office or remotely by the patient. The data can then be reviewed by clinicians through the KardiaPro physician portal, which can integrate with existing practice workflows, including EHR systems.

Related Tools

Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA
Cardiology AI
Siemens Healthineers offers the ACUSON Sequoia, ACUSON Sequoia Select, and ACUSON Origin ultrasound systems, providing advanced imaging for various medical needs. The Sequoia line focuses on high-resolution imaging with deep penetration and reduced variability, while the AI-powered ACUSON Origin specializes in comprehensive cardiovascular diagnostics and interventions.
R30 Diagnostic Ultrasound System
Samsung Medison Co.
Cardiology AI
The Samsung Medison R30 Diagnostic Ultrasound System is a general-purpose, mobile, software-controlled diagnostic ultrasound system that offers a wide range of imaging capabilities and analysis tools for various clinical applications.

See all Cardiology AI tools →

More from AliveCor

Corvair
AliveCor
Cardiology AI
Corvair Monza
AliveCor
Cardiology AI
AliveCor is a medical device and AI company that develops ECG hardware and software compatible with consumer mobile devices for remote heart rhythm monitoring and arrhythmia detection. Their products, such as the KardiaMobile, KardiaMobile 6L, and KardiaMobile Card, provide medical-grade ECG readings and utilize AI for analysis. AliveCor aims to deliver intelligent, highly-personalized heart data to clinicians and patients anytime, anywhere, transforming cardiology.
Impala
AliveCor
Cardiology AI
AliveCor specializes in cardiac monitoring solutions.
Kardia 12L and KAI 12L
AliveCor
Cardiology AI
Kardia 12L and KAI 12L offer a portable, AI-powered 12-lead ECG system for healthcare professionals, enabling rapid and accurate detection of numerous cardiac conditions with a simplified setup.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-10-14 | First Added: 2026-04-17

Investors who backed AliveCor QT Service

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.